Hyaluronate and Derivatives and Omeprazole Delayed-Release Capsules
Determining the interaction of Hyaluronate and Derivatives and Omeprazole Delayed-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: omeprazole
Brand name: FIRST Omeprazole, Omeprazole + SyrSpend SF Alka, Prilosec, Prilosec OTC, Zegerid>, Prilosec, Prilosec OTC
Synonyms: Omeprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Omeprazole Delayed-Release Capsules and Tablets (OTC)
- Hyaluronate and Derivatives-Omeprazole Orally-Disintegrating Tablets
- Hyaluronate and Derivatives-Omeprazole Powder for Oral Suspension
- Hyaluronate and Derivatives-Omeprazole Tablets
- Hyaluronate and Derivatives-Omeprazole, Clarithromycin, and Amoxicillin
- Hyaluronate and Derivatives-Omidria
- Omeprazole Delayed-Release Capsules-Hyaluronate and Derivatives Injection (Knee)
- Omeprazole Delayed-Release Capsules-Hyaluronate sodium Injection
- Omeprazole Delayed-Release Capsules-Hyaluronidase
- Omeprazole Delayed-Release Capsules-Hyaluronidase and immune globulin
- Omeprazole Delayed-Release Capsules-Hyaluronidase and rituximab
- Omeprazole Delayed-Release Capsules-Hyaluronidase and trastuzumab